Noema Pharma raised CHF 103 million in Series B funding led by Forbion and joined by Jeito Capital, UPMC, Sofinnova Partners, Gilde Healthcare and Invus Biotech Health services Investments 03 March 2023 Share: Interested in more dealflow and deeper data sets from Europe? Please consider joining Nordic 9!
Round value (USD): 109.46M Round investors: Polaris PartnersSofinnova PartnersUPMC EnterprisesForbion Capital PartnersGilde HealthcareJeito CapitalInvus Company: Noema Pharma Industry: BiotechHealth services
GlycoEra raised $130m in Series B led by Novo, joined by Catalio Capital, LifeArc Ventures, QIA, Sixty Degree Capital, Agent Capital, MP Healthcare, Sofinnova. Biotech Health services Pharma Investments 17 May 2025